The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years September 14, 2017 The Next Biotech 'Unicorn,' Ginkgo Bioworks, Just Nabbed Another $275M December 13, 2017 Why Struggling Bristol-Myers Squibb Could Take Out This Danish Biotech in Major ???500M Deal March 20, 2017
Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years September 14, 2017
Why Struggling Bristol-Myers Squibb Could Take Out This Danish Biotech in Major ???500M Deal March 20, 2017